{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_35", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "along with the motherâ€™s clinical need for \nTRADENAME and any potential adverse effects \non the breastfed child from TRADENAME or from \nthe underlying maternal condition. \nExample:  \n8.2 Lactation- Risk Summary-  \nSafety Concerns \nRisk Summary \n[Drugname] is present in human milk. A published lactation study reports \nvariable concentrations of [drugname] and an active metabolite in breast \nmilk with administration of immediate-release [drugname] to nursing \nmothers in the early post-partum period"}